Nisa Investment Advisors LLC decreased its position in shares of CVS Health Corporation (NYSE:CVS) by 1.3% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 442,207 shares of the pharmacy operator’s stock after selling 5,787 shares during the period. Nisa Investment Advisors LLC’s holdings in CVS Health Corporation were worth $35,364,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the stock. LS Investment Advisors LLC boosted its stake in shares of CVS Health Corporation by 1.1% in the second quarter. LS Investment Advisors LLC now owns 207,327 shares of the pharmacy operator’s stock worth $16,682,000 after buying an additional 2,240 shares in the last quarter. Middleton & Co Inc MA boosted its stake in shares of CVS Health Corporation by 23.6% in the second quarter. Middleton & Co Inc MA now owns 77,346 shares of the pharmacy operator’s stock worth $6,223,000 after buying an additional 14,780 shares in the last quarter. Sky Investment Group LLC boosted its stake in shares of CVS Health Corporation by 0.9% in the second quarter. Sky Investment Group LLC now owns 15,393 shares of the pharmacy operator’s stock worth $1,239,000 after buying an additional 134 shares in the last quarter. Watch Point Trust Co boosted its stake in shares of CVS Health Corporation by 2.6% in the second quarter. Watch Point Trust Co now owns 30,532 shares of the pharmacy operator’s stock worth $2,457,000 after buying an additional 775 shares in the last quarter. Finally, YCG LLC boosted its stake in shares of CVS Health Corporation by 0.4% in the second quarter. YCG LLC now owns 80,051 shares of the pharmacy operator’s stock worth $6,441,000 after buying an additional 344 shares in the last quarter. Institutional investors and hedge funds own 81.92% of the company’s stock.
Shares of CVS Health Corporation (NYSE CVS) opened at 77.97 on Monday. The stock has a market cap of $79.44 billion, a P/E ratio of 16.26 and a beta of 0.91. The stock’s 50 day moving average is $78.75 and its 200 day moving average is $79.09. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $98.44.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.57%. The ex-dividend date of this dividend was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio (DPR) is 41.67%.
COPYRIGHT VIOLATION WARNING: “Nisa Investment Advisors LLC Sells 5,787 Shares of CVS Health Corporation (CVS)” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://stocknewstimes.com/2017/08/07/cvs-health-corporation-cvs-shares-sold-by-nisa-investment-advisors-llc-updated.html.
A number of brokerages have weighed in on CVS. BidaskClub upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a research report on Friday, July 14th. Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Needham & Company LLC began coverage on shares of CVS Health Corporation in a research report on Tuesday, June 27th. They set a “hold” rating for the company. Finally, Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the company a “buy” rating in a research report on Tuesday, June 27th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. CVS Health Corporation currently has a consensus rating of “Buy” and an average target price of $92.20.
In other news, CFO David M. Denton sold 230,510 shares of the stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares in the company, valued at approximately $14,158,640. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Helena Foulkes sold 20,332 shares of the stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the transaction, the executive vice president now owns 59,300 shares of the company’s stock, valued at $4,564,914. The disclosure for this sale can be found here. Insiders sold 271,175 shares of company stock valued at $21,632,597 in the last ninety days. 0.61% of the stock is owned by corporate insiders.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
